TQR Stock Overview
Beijing Tong Ren Tang Chinese Medicine Company Limited, junto con sus filiales, se dedica a la fabricación, venta al por menor y al por mayor de medicina china y productos sanitarios a mayoristas y particulares.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.05 |
| 52 Week High | HK$1.89 |
| 52 Week Low | HK$1.03 |
| Beta | 0.40 |
| 1 Month Change | -1.87% |
| 3 Month Change | -21.64% |
| 1 Year Change | -35.58% |
| 3 Year Change | -16.00% |
| 5 Year Change | -37.16% |
| Change since IPO | 14.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| TQR | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -5.8% | -0.6% |
| 1Y | -35.6% | -31.3% | 4.9% |
Rentabilidad frente al sector: TQR obtuvo unos resultados inferiores a los del sector German Pharmaceuticals , que el año pasado arrojó un rendimiento del -25.6%.
Rentabilidad vs. Mercado: TQR obtuvo unos resultados inferiores a los del mercado German, que fue del -1.4% el año pasado.
Price Volatility
| TQR volatility | |
|---|---|
| TQR Average Weekly Movement | 6.6% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 9.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: TQRha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de TQR (7%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1669 | 798 | Fei Chen | https://www.tongrentangcm.com |
Beijing Tong Ren Tang Chinese Medicine Company Limited, junto con sus filiales, se dedica a la fabricación, venta al por menor y al por mayor de medicina china y productos sanitarios a mayoristas y particulares. La empresa opera a través de tres segmentos: Hong Kong, China continental y ultramar. También ofrece servicios de consulta y tratamiento de medicina china.
Beijing Tong Ren Tang Chinese Medicine Company Limited Fundamentals Summary
| TQR fundamental statistics | |
|---|---|
| Market cap | €886.10m |
| Earnings (TTM) | €63.56m |
| Revenue (TTM) | €179.36m |
13.9x
P/E Ratio4.9x
P/S RatioIs TQR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TQR income statement (TTM) | |
|---|---|
| Revenue | HK$1.52b |
| Cost of Revenue | HK$477.70m |
| Gross Profit | HK$1.05b |
| Other Expenses | HK$506.85m |
| Earnings | HK$540.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.65 |
| Gross Margin | 68.67% |
| Net Profit Margin | 35.44% |
| Debt/Equity Ratio | 0.008% |
How did TQR perform over the long term?
See historical performance and comparisonDividends
3.7%
Current Dividend Yield51%
Payout RatioDoes TQR pay a reliable dividends?
See TQR dividend history and benchmarks| Beijing Tong Ren Tang Chinese Medicine dividend dates | |
|---|---|
| Ex Dividend Date | Jun 04 2024 |
| Dividend Pay Date | Jun 17 2024 |
| Days until Ex dividend | 56 days |
| Days until Dividend pay date | 69 days |
Does TQR pay a reliable dividends?
See TQR dividend history and benchmarks